Nathalie Ballet
Marcq, 59700, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evaluation of Biofilm Inhibitory Activity of Probiotics and Postbiotics Using In Vitro Biofilm Model of Canine Periodontal Disease.
Journal: Microorganisms
Published: July 30, 2025
Yeast cell wall derivatives as a potential strategy for modulating oral microbiota and dental plaque biofilm.
Journal: Frontiers in oral health
Published: December 11, 2024
Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856.
Journal: Scientific reports
Published: June 13, 2023
Impacts of Menstruation, Community Type, and an Oral Yeast Probiotic on the Vaginal Microbiome.
Journal: mSphere
Published: September 14, 2022
Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models.
Journal: Gut microbes
Published: August 25, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's disease.
Journal: United European gastroenterology journal
Published: March 25, 2021
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis.
Journal: Microorganisms
Published: July 27, 2020
Spatial and temporal modulation of enterotoxigenic E. coli H10407 pathogenesis and interplay with microbiota in human gut models.
Journal: BMC biology
Published: April 07, 2020
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis.
Journal: Frontiers in microbiology
Published: April 08, 2019
Last Updated: 09/26/2026